{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.2:c.77G>A",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "G",
            "alt": "A",
            "position": "77"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "26"
          },
          "Description in input context": "E26K mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005228"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin T (ThT) fluorescence assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Recombinant alpha-synuclein",
        "Description": "The experiment was conducted using recombinant alpha-synuclein proteins with the E26K mutation and wild-type controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.2:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E26K variant exhibited significantly increased fibril formation compared to wild-type, as measured by enhanced ThT fluorescence intensity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Biological replicates were not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Technical replicates were not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit negative control was described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ThT fluorescence intensity within 10% of wild-type levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ThT fluorescence intensity exceeding 50% of wild-type levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}